IWC
TNYA icon

Integrated Wealth Concepts’s Tenaya Therapeutics TNYA Stock Holding History

Integrated Wealth Concepts’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.6K Buy
23,940
+2,000
+9% +$1.48K ﹤0.01% 2263
2025
Q4 		$15.6K Sell
21,940
-92
-0.4% -$125 ﹤0.01% 1596
2025
Q3 		$35.7K Sell
22,032
-3,906
-15% -$3.93K ﹤0.01% 1958
2025
Q2 		$15.9K Sell
25,938
-1,379
-5% -$702 ﹤0.01% 1890
2025
Q1 		$15.6K Buy
27,317
+3,377
+14% +$3.33K ﹤0.01% 1724
2024
Q4 		$34.2K Buy
23,940
+7,000
+41% +$15.7K ﹤0.01% 1698
2024
Q3 		$32.7K Buy
16,940
+1,940
+13% +$5.48K ﹤0.01% 1650
2024
Q2 		$46.5K Hold
15,000
– – ﹤0.01% 1617
2024
Q1 		$78.5K Hold
15,000
– – ﹤0.01% 1596
2023
Q4 		$48.6K Buy
15,000
+5,000
+50% +$10.8K ﹤0.01% 1563
2023
Q3 		$25.5K Hold
10,000
– – ﹤0.01% 1533
2023
Q2 		$58.7K Sell
10,000
-5,000
-33% -$29.1K ﹤0.01% 1510
2023
Q1 		$43K Buy
15,000
+5,000
+50% +$14.1K ﹤0.01% 1306
2022
Q4 		$20K Buy
+10,000
New +$24.4K ﹤0.01% 1020

Other funds holding TNYA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
BGM
Burkehill Global Management New York $2.02B AUM 85.32% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $141M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Integrated Wealth Concepts's TNYA Position: Q1 2026 in Review

Integrated Wealth Concepts increased its Tenaya Therapeutics (TNYA) stake by 9.1% in Q1 2026, buying an estimated $1.48K and bringing the position to 23,940 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2263.

Integrated Wealth Concepts first reported a position in TNYA in Q4 2022 and has held it in 14 quarters since. The position peaked at $78.5K in Q1 2024. 103 funds tracked by Wall St. Rank hold TNYA as of Q1 2026.

  • Integrated Wealth Concepts held 23,940 shares of Tenaya Therapeutics worth $16.6K as of Q1 2026.
  • Integrated Wealth Concepts bought 2,000 Tenaya Therapeutics shares in Q1 2026, an estimated $1.48K.
  • Tenaya Therapeutics made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #2263 holding.
  • Integrated Wealth Concepts first reported a position in Tenaya Therapeutics in Q4 2022 and has held it in 14 quarters since.
  • Integrated Wealth Concepts's Tenaya Therapeutics position peaked at $78.5K in Q1 2024.
  • 103 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q1 2026.

Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.